Opus Genetics, Inc. · NASDAQ:IRD
Perceptive Advisors LLC reported a 9.99% stake in Opus Genetics, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
Perceptive Advisors LLC reported a 9.99% stake in Opus Genetics, Inc., 7,174,154 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 9.99%
- Shares
- 7,174,154
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Perceptive Advisors LLC | 9.99% | 7,174,154 |
| Joseph Edelman | 9.99% | 7,174,154 |
| Perceptive Life Sciences Master Fund, Ltd. | 9.99% | 7,174,154 |
Source
Related
- Opus Genetics, Inc.
- Perceptive Advisors LLC
- Opus Genetics, Inc. shareholders
- Schedule 13G/A · Perceptive Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Perceptive Advisors LLC · May 15, 2026
- Schedule 13G · Perceptive Advisors LLC · Mar 31, 2025
- Form 4 · Foundation Fighting Blindness Retinal Degeneration Fund · Oct 2, 2026
- Form 4 · Magrath George · Sep 11, 2026
- Form 4 · Gallagher Cam · Sep 8, 2026
- Form 4 · Gagnon Robert E. · Sep 8, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Aug 14, 2026